Molecule Details
| InChIKey | SALBBGQOFCZHKF-UHFFFAOYSA-N |
|---|---|
| Compound Name | 1-[3-tert-butyl-1-[4-(2-morpholin-4-ylethoxy)phenyl]pyrazol-5-yl]-3-[4-[2-[(3,3-dimethyl-2-oxo-1H-indol-6-yl)amino]pyrimidin-4-yl]oxynaphthalen-1-yl]urea |
| Canonical SMILES | CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4ccc5c(c4)NC(=O)C5(C)C)n3)c3ccccc23)n(-c2ccc(OCCN3CCOCC3)cc2)n1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.79 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile